Clinical Trials

    Showing 1 - 2 of 2 Viral Infections

    The COVID-19 and Cancer Consortium CCC19 Registry

    Status: Open Not Enrolling

    Investigator: Jun Zhang

    Study Coordinator:

    Phone:

    Cancer patients have an almost unique risk profile in this pandemic. Many patients, especially those actively on treatment, have high levels of contact with the healthcare system. Many if not all cancer patients are immunocompromised, through the imm... Read more >

    Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine

    Status: Enrolling

    Investigator: Eleftherios Mylonakis

    Study Coordinator: Diana Avila

    Phone: 786.718.8946

    The goal of this research is to learn more about ZADAXIN® (trade name; thymalfasin generic; Ta1 for short) and determine if Ta1 has any benefit in increasing the immune response to the COVID-19 vaccine. Ta1 has been shown to stimulate the immune syst... Read more >